Forsight team (from website)
Israeli medtech startup ForSight Robotics is developing a surgical robotic platform to deliver what it describes as high precision and cost-effective vision-saving surgery. Forsight just raised $55 million in a Series A round of funding led by The Adani Group alongside existing investors Eclipse Ventures and Mithril Capital.
Forsight Raised $10 million in seed funding in March 2021.
Founded in 2020 CEO Daniel Glozman, Ph.D., Joseph Nathan, M.D. and Moshe Shoham, Ph.D, Forsight declares that its mission is to transform the practice of ophthalmic surgery through a next generation robotic platform combining “state of the art robotic microsurgical technology, advanced visualization technologies, and next generation cognitive computing methods.”
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Joseph Nathan previously directed healthcare commercialization at the Technion Israel Institute of Technology, where he forged partnerships worth over $1 billion with global pharmaceutical and med-tech companies. Daniel Glozman has specialized in robotics for medical applications for over 20 years, heading R&D at Medtronic Ventor Technologies, Magenta Medical, Diagnostic Robotics, and Guide-X — which he also founded.
Israeli medical professionals have been behind many new procedures to save people’s vision over the years. Losing your vision is one of the most frightening things which can happen to people. Israeli startup OrCam produces new technology for the blind and other people with visual deficiencies. Its MyEye is wearable technology that can give eyesight to the blind. But it does not heal them.
Forsight Robotics, however, tries to heal blindness. The company explains that many of the leading causes of blindness worldwide can be prevented through timely surgical procedures. Ophthalmic microsurgery is complex and challenging, requiring many years to master, and there is a shortage of trained ophthalmic surgeons to meet the demand worldwide. Creation of a robotic surgical platform will allow one to deliver consistent excellent results while scaling up ophthalmic surgery to solve the problem of preventable blindness worldwide.
“These are exciting times that will enable the transformation of ophthalmic surgery from art to science,” Forsight’s Dr. Joseph Nathan once declared.
“We are thrilled to bring robotics into the world of ophthalmic surgery,” Dr. Glozman once said. “Our goal is to democratize this highly sophisticated procedure, enabling patients around the world to easily access the treatment that can restore their vision.”
